No abstract

These findings suggest that clinical decisions related to the timing of discharge and follow-up modify EHR risk after KT, independent of traditional risk factors.

No abstract

Patients with cancer are at risk for acute and chronic renal injury. The insult could be from the malignancy directly or a paraneoplastic process or due to treatment. In addition, cancer and its treatments can also lead to electrolyte and acid-base disorders, as well as hypertension. Monitoring kidney function in patients with cancer is important for early detection and management of these complications. This is also important for patients on newer cancer treatments whose renal effects may not be well known. In patients for whom nephrotoxicity is anticipated, specific precautions can be taken for its prevention. This chapter discusses direct tumor involvement of the kidney and treatment-associated kidney disease and closes by examining tumor lysis syndrome and kidney disease after hematopoietic cell transplantation.

No abstract